Age, median (range) (years) | 67.5 (40–84) |
Gender, n (%)/n (%) (male/female) | 23 (57.5%) /17 (42.5%) |
Digestive symptoms, n (%)/n (%) (+/−)a | 11 (27.5%) /29 (72.5%) |
Clinical subtypes of ATLL, n (%)/n (%)/n (%)/n (%) (acute/lymphoma/chronic/smoldering) | 23 (57.5%) /6 (15.0%) /5 (12.5%) /6 (15.0%) |
Superficial lymphadenopathy, n (%)/n (%) (+/−) | 26 (65.0%) /14 (35.0%) |
Hepatosplenomegaly, n (%)/n (%) (+/−) | 17 (42.5%) /23 (57.5%) |
Skin lesions, n (%)/n (%) (+/−) | 26 (65.0%) /14 (35.0%) |
Opportunistic infections, n (%)/n (%) (+/−)b | 15 (37.5%) /25 (62.5%) |